Latest stories

  • in

    Dr Reddys Labs concludes acquisition of Mayne Pharma’s US generic prescription product portfolio

    Dr Reddys Labs concludes acquisition of Mayne Pharma's US generic prescription product portfolio

    Hyderabad: Pharma major, Dr Reddys Labs, has recently announced that the company has completed the acquisition of Mayne Pharma’s U.S. generic prescription product portfolio. The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health. For the financial period ended June […] More

  • in

    CDSCO Drug Alert: 59 Drug Samples Including Sun Pharma’s Montek LC, Alkem’s Pan 40, Glenmark’s Telma 40 Flagged

    New Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 59 medicine batches for failing to qualify for a random drug sample test for the month of February– 2023. These drug samples include Talwar Pharma’s Omeprazole Capsules, Cris Pharma’s Levocetirizine Tablets, Apple Formulation’s Levocetirizine […] More